Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The **ethanol extract of Cassia siamea Lam leaves** is a plant-derived preparation known for a range of traditional medicinal uses, especially in Southeast Asia and Africa. Scientific studies support its potent **antidiabetic**, **antioxidant**, **anti-inflammatory**, **antimicrobial**, and **analgesic** properties. Its mechanism of action in diabetes involves both insulin-dependent and insulin-independent pathways, including **inhibition of α-amylase**, improvement of insulin sensitivity, and reduction of oxidative stress and inflammation[1][3][5]. Phytochemical screening reveals that this extract is rich in **alkaloids**, **flavonoids**, **saponins**, **triterpenoids**, **phenolic compounds**, **steroids**, and **anthraquinones**—all contributing to its pharmacological effects[1][2][3][7]. Barakol, a notable component, is credited with sedative and anxiolytic activity[2][8]. Research has shown that the extract improves glucose and insulin homeostasis, reduces hepatic inflammation, prevents vascular dysfunction, and exhibits antibacterial effects against several pathogens[3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ethanol extract of cassia siamea lam leaves.